<DOC>
	<DOCNO>NCT00979615</DOCNO>
	<brief_summary>The purpose study examine safety efficacy Patanase Astelin treat symptom non-allergic vasomotor rhinitis ( VMR ) .</brief_summary>
	<brief_title>Safety Efficacy Olopatadine 0.6 % Azelastine 137 Mcg Vasomotor Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Vasomotor</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<mesh_term>Azelastine</mesh_term>
	<criteria>Diagnosis VMR least 2 year chronic nonallergic rhinitis Negative skin test panel allergens positive histamine test within last 2 year History symptom relate defined VMR trigger Nasal disorder , surgery , concurrent disease could interfere evaluation study medication Bacterial viral infection within 14 day first visit . Diagnosis acute sinusitis within 30 day first visit Chronic use drug cause rhinitis</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>vasomotor rhinitis</keyword>
	<keyword>chronic non-allergic rhinitis</keyword>
	<keyword>VMR</keyword>
</DOC>